You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-IL34 (IL34) Antibodies

Full name:
anti-Interleukin 34 Antibodies (IL34)
On www.antibodies-online.com are 99 Interleukin 34 (IL34) Antibodies from 20 different suppliers available. Additionally we are shipping IL34 Kits (54) and IL34 Proteins (29) and many more products for this protein. A total of 190 IL34 products are currently listed.
Synonyms:
2010004A03Rik, AI593503, C16orf77, C18H16ORF77, IL-34

Most Popular Reactivities for anti-IL34 (IL34) Antibodies

Select your species and application

anti-Human IL34 Antibodies:

anti-Mouse (Murine) IL34 Antibodies:

anti-Rat (Rattus) IL34 Antibodies:

All available anti-IL34 Antibodies

Go to our pre-filtered search.

Top referenced anti-IL34 Antibodies

  1. Mouse (Murine) Polyclonal IL34 Primary Antibody for BR, FACS - ABIN2660791 : Lin, Lee, Hestir, Leo, Huang, Bosch, Halenbeck, Wu, Zhou, Behrens, Hollenbaugh, Linnemann, Qin, Wong, Chu, Doberstein, Williams: Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. in Science (New York, N.Y.) 2008 (PubMed)
    Show all 5 references for ABIN2660791

  2. Human Monoclonal IL34 Primary Antibody for FACS - ABIN2660793 : Chihara, Suzu, Hassan, Chutiwitoonchai, Hiyoshi, Motoyoshi, Kimura, Okada: IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation. in Cell death and differentiation 2010 (PubMed)
    Show all 5 references for ABIN2660793

  3. Mouse (Murine) Monoclonal IL34 Primary Antibody for BR, FACS - ABIN2665836 : Covaleda, Fuller, Payne: EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages. in Virology 2010 (PubMed)
    Show all 5 references for ABIN2665836

  4. Human Monoclonal IL34 Primary Antibody for FACS - ABIN4896347 : Bézie, Picarda, Ossart, Tesson, Usal, Renaudin, Anegon, Guillonneau: IL-34 is a Treg-specific cytokine and mediates transplant tolerance. in The Journal of clinical investigation 2015 (PubMed)

  5. Human Monoclonal IL34 Primary Antibody for ICC, FACS - ABIN969216 : Slomiany, Baker, Elliott, Grossel: Changes in motility, gene expression and actin dynamics: Cdk6-induced cytoskeletal changes associated with differentiation in mouse astrocytes. in Journal of cellular biochemistry 2006 (PubMed)

More Antibodies against IL34 Interaction Partners

Human Interleukin 34 (IL34) interaction partners

  1. The current study aimed to assess the IL-34 expression in response to two members of the transforming growth factor (TGF)-beta family, TGF-beta1 and bone morphogenetic protein (BMP)-2, in synovial fibroblasts from rheumatoid arthritis patients.

  2. The receiver operating characteristic (ROC) curve analysis has shown that IL-34 has more discriminatory power than C-reactive protein (CRP (show CRP Antibodies)) for the risk of diabetic complications. The cut-off value for IL-34 was established as 91.2 pg/mL. The gist of our research was identification of IL-34 as an additional potential inflammatory biomarker for the prediction of the risk of vascular diabetic complications.

  3. miR (show MLXIP Antibodies)-28-5p-IL-34-macrophage feedback loop modulates hepatocellular carcinoma metastasis

  4. findings demonstrated that M-CSF (show CSF1 Antibodies) binds to IL-34; molecular docking studies predicted the formation of a heteromeric M-CSF (show CSF1 Antibodies)/IL-34 cytokine

  5. These results suggest that IL-34, a novel osteoclastogenic cytokine, plays a role in rheumatoid arthritis-associated joint damage and is a potential biomarker for predicting subsequent radiographic progression in patients with RA.

  6. IL-34 is expressed by human FOXP3 (show FOXP3 Antibodies)+CD45RCloCD8+ and CD4 (show CD4 Antibodies)+ Tregs and markedly inhibited alloreactive immune responses.

  7. This paper provides evidence of alternative binding of IL-34 to chondroitin sulphates and syndecan-1 (show SDC1 Antibodies) at the cell surface that modulates M-CSFR (show CSF1R Antibodies) activation.

  8. In vitro and in vivo experiments indicate that IL-34 expression is regulated by TNF-a (show TNF Antibodies) and IL-1b (show IL1B Antibodies) and that its overexpression is associated with an increase in osteosarcoma growth and metastasis.

  9. the expression pattern of IL-34 in ileum and colon and suggest IL-34 as a new modulator of inflammation in inflammatory bowel disease

  10. IL-34 is up-regulated in inflammatory bowel disease and suggest a role for this cytokine in sustaining the inflammatory responses in this disease

Mouse (Murine) Interleukin 34 (IL34) interaction partners

  1. The current study aimed to assess the IL-34 expression in response to two members of the transforming growth factor (TGF)-beta family, TGF-beta1 and bone morphogenetic protein (BMP)-2, in synovial fibroblasts from rheumatoid arthritis patients.

  2. study concludes that Langerhans cells require IL-34 when residing in fully differentiated and anatomically intact skin epidermis, but rely on neutrophil-derived CSF1 (show CSF1 Antibodies) during inflammation

  3. constitutive IL-34 expressed by skin keratinocytes might suppress resident macrophage responses to C. albicans colonisation by maintaining low levels TLR2 (show TLR2 Antibodies) and Dectin-1 (show CLEC7A Antibodies) expression by macrophages.

  4. IL-34 protected blood-brain barrier integrity by restored expression levels of tight junction proteins, which were downregulated by pro-inflammatory cytokines.

  5. IL-34-dependent, Mo-mediated, CSF-1 (show CSF1 Antibodies) nonredundant mechanisms promote persistent ischemia-incited AKI that worsens subsequent CKD.

  6. In vitro and in vivo experiments indicate that IL-34 expression is regulated by TNF-a (show TNF Antibodies) and IL-1b (show IL1B Antibodies) and that its overexpression is associated with an increase in osteosarcoma growth and metastasis.

  7. the expression pattern of IL-34 in ileum and colon and suggest IL-34 as a new modulator of inflammation in inflammatory bowel disease

  8. Tumor necrosis factor-alpha (show TNF Antibodies) induces IL-34 expression via NF-kappaB (show NFKB1 Antibodies) in MC3T3-E1 osteoblastic cells.

  9. These findings suggest that TGF-beta (show TGFB1 Antibodies) produced by IL-34-treated microglia is a negative regulator of microglial proliferation and enhances the neuroprotective property of microglia.

  10. Differentiated signaling between IL-34 and CSF-1 (show CSF1 Antibodies) is likely achieved by the relative thermodynamic independence of IL-34 versus negative cooperativity of CSF-1 (show CSF1 Antibodies) at the CSF-1 receptor (show CSF1R Antibodies) recognition sites.

IL34 Antigen Profile

Antigen Summary

Interleukin-34 is a cytokine that promotes the differentiation and viability of monocytes and macrophages through the colony-stimulating factor-1 receptor (CSF1R\; MIM 164770) (Lin et al., 2008

Alternative names and synonyms associated with IL34

  • interleukin 34 (IL34) antibody
  • interleukin 34 (Il34) antibody
  • interleukin 34 (LOC100347811) antibody
  • interleukin-34-like (LOC100737468) antibody
  • 2010004A03Rik antibody
  • AI593503 antibody
  • C16orf77 antibody
  • C18H16ORF77 antibody
  • IL-34 antibody

Protein level used designations for anti-Interleukin 34 (IL34) Antibodies

interleukin 34 , interleukin-34 , IL-34

GENE ID SPECIES
454217 Pan troglodytes
100499188 Taeniopygia guttata
146433 Homo sapiens
76527 Mus musculus
498951 Rattus norvegicus
100347811 Oryctolagus cuniculus
100723831 Cavia porcellus
508292 Bos taurus
610536 Canis lupus familiaris
100858424 Gallus gallus
101113261 Ovis aries
100737468 Sus scrofa
Selected quality suppliers for anti-IL34 (IL34) Antibodies
Did you look for something else?